CN117912631A - 具有适应性靶葡萄糖水平的基础滴定 - Google Patents

具有适应性靶葡萄糖水平的基础滴定 Download PDF

Info

Publication number
CN117912631A
CN117912631A CN202311662916.9A CN202311662916A CN117912631A CN 117912631 A CN117912631 A CN 117912631A CN 202311662916 A CN202311662916 A CN 202311662916A CN 117912631 A CN117912631 A CN 117912631A
Authority
CN
China
Prior art keywords
glucose
measure
subset
central tendency
time window
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202311662916.9A
Other languages
English (en)
Chinese (zh)
Inventor
T.B.阿拉多蒂尔
H.本特松
M.L.简森
P.布洛克迈尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority claimed from PCT/EP2018/065126 external-priority patent/WO2018228932A1/en
Publication of CN117912631A publication Critical patent/CN117912631A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or Bluetooth®
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
CN202311662916.9A 2017-06-15 2018-06-08 具有适应性靶葡萄糖水平的基础滴定 Pending CN117912631A (zh)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201762520139P 2017-06-15 2017-06-15
US62/520139 2017-06-15
US201762522811P 2017-06-21 2017-06-21
US62/522811 2017-06-21
EP17178877.1 2017-06-29
EP17178877 2017-06-29
EP17190146 2017-09-08
EP17190146.5 2017-09-08
CN201880039764.8A CN110741438B (zh) 2017-06-15 2018-06-08 具有适应性靶葡萄糖水平的基础滴定
PCT/EP2018/065126 WO2018228932A1 (en) 2017-06-15 2018-06-08 Basal titration with adaptive target glucose level

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201880039764.8A Division CN110741438B (zh) 2017-06-15 2018-06-08 具有适应性靶葡萄糖水平的基础滴定

Publications (1)

Publication Number Publication Date
CN117912631A true CN117912631A (zh) 2024-04-19

Family

ID=62492661

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202311662916.9A Pending CN117912631A (zh) 2017-06-15 2018-06-08 具有适应性靶葡萄糖水平的基础滴定
CN201880039764.8A Active CN110741438B (zh) 2017-06-15 2018-06-08 具有适应性靶葡萄糖水平的基础滴定

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201880039764.8A Active CN110741438B (zh) 2017-06-15 2018-06-08 具有适应性靶葡萄糖水平的基础滴定

Country Status (5)

Country Link
US (2) US11298461B2 (https=)
EP (2) EP3758008A1 (https=)
JP (2) JP7178370B2 (https=)
CN (2) CN117912631A (https=)
MA (1) MA49422A (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3826700A1 (en) * 2018-07-26 2021-06-02 Sanofi Method of adjusting medication doses
AU2023260398A1 (en) 2022-04-26 2024-11-21 Dexcom, Inc. System and method for titrating basal insulin doses
WO2024192362A1 (en) * 2023-03-16 2024-09-19 University Of Virginia Method for mitigating hypoglycemia rebound in an automated insulin delivery system
JPWO2024214253A1 (https=) * 2023-04-13 2024-10-17
WO2025090855A1 (en) * 2023-10-26 2025-05-01 University Of Virginia Patent Foundation Targeted basal insulin titration using sparse and dense glucose measurements

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110319322A1 (en) * 2008-04-04 2011-12-29 Hygieia, Inc. Systems, Methods and Devices for Achieving Glycemic Balance
US20120232520A1 (en) * 2011-03-10 2012-09-13 Abbott Diabetes Care Inc. Multi-Function Analyte Monitor Device and Methods of Use
TW201318602A (zh) * 2011-11-14 2013-05-16 Joinsoon Medical Technology Co Ltd 具胰島素參數之血糖檢測統計方法及其血糖檢測機

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127370A (en) 1998-12-02 2004-05-12 Yaskawa Eshed Technology Ltd Control system and method for servo mechanism
US6923763B1 (en) 1999-08-23 2005-08-02 University Of Virginia Patent Foundation Method and apparatus for predicting the risk of hypoglycemia
US7404796B2 (en) 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
US20050065760A1 (en) * 2003-09-23 2005-03-24 Robert Murtfeldt Method for advising patients concerning doses of insulin
US20070092888A1 (en) 2003-09-23 2007-04-26 Cornelius Diamond Diagnostic markers of hypertension and methods of use thereof
JP4273036B2 (ja) 2004-05-12 2009-06-03 中 奥村 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム
US7509156B2 (en) * 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
DK1972270T3 (da) 2007-03-23 2011-01-24 Hoffmann La Roche Fremgangsmåde og glucoseovervågningssystem til overvågning af individuelt metabolisk respons
EP2156684A4 (en) 2007-05-14 2012-10-24 Abbott Diabetes Care Inc METHOD AND DEVICE FOR PROVIDING DATA PROCESSING AND CONTROL IN A MEDICAL COMMUNICATION SYSTEM
EP4159114B1 (en) * 2007-10-09 2024-04-10 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
EP2245568A4 (en) 2008-02-20 2012-12-05 Univ Mcmaster EXPERIMENTAL SYSTEM FOR DETERMINING THE RESPONSE OF PATIENTS TO TREATMENT
PT2260423T (pt) 2008-04-04 2018-05-30 Hygieia Inc Aparelho para optimizar o regime de dosagem de insulina a um paciente
TWI394580B (zh) * 2008-04-28 2013-05-01 Halozyme Inc 超快起作用胰島素組成物
US20100256047A1 (en) * 2009-04-03 2010-10-07 Lifescan, Inc. Analyte Measurement and Management Device and Associated Methods
US8175812B2 (en) 2008-06-25 2012-05-08 Roche Diagnostics Operations, Inc. Method, system, and computer program product for calculating daily weighted averages of glucose measurements (or derived quantities) with time-based weights
WO2010089307A1 (en) * 2009-02-04 2010-08-12 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing information for glycemic control
US8562587B2 (en) 2009-02-25 2013-10-22 University Of Virginia Patent Foundation CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction of insulin delivery
JP5654587B2 (ja) 2009-06-30 2015-01-14 ライフスキャン・インコーポレイテッドＬｉｆｅｓｃａｎ，Ｉｎｃ． 基礎インスリン療法を算出する分析物試験方法及び装置
WO2011084208A1 (en) 2009-12-21 2011-07-14 Stc.Unm System and methods for estimating hba1c, treatment response, and hypoglycemia risk using self-monitoring of blood glucose data
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
RU2602040C2 (ru) 2011-08-26 2016-11-10 Университи Оф Вирджиния Патент Фоундэйшион Способ, система и машиночитаемый носитель для адаптационного рекомендательного контроля сахарного диабета
TW201333870A (zh) * 2011-12-21 2013-08-16 艾登工具股份有限公司 決定病人胰島素療法的系統及方法
US9227014B2 (en) 2013-02-07 2016-01-05 The Board Of Trustees Of The Laland Stanford Junior University Kalman filter based on-off switch for insulin pump
EP2967344A4 (en) 2013-03-15 2016-11-23 Abbott Diabetes Care Inc DEVICES, SYSTEMS AND METHODS RELATING TO ANALYTICAL MONITORING DEVICES AND DEVICES THEREWITH
EP4420603A3 (en) 2013-03-15 2024-11-20 Abbott Diabetes Care, Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
US20150006192A1 (en) 2013-06-26 2015-01-01 WellDoc, Inc. Systems and methods for clinical decision-making
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
WO2015128740A2 (en) 2014-02-28 2015-09-03 Eco-Fusion Systems for predicting hypoglycemia and methods of use thereof
US10722650B2 (en) 2014-03-28 2020-07-28 Roche Diabetes Care, Inc. System and method for adjusting therapy based on risk associated with a glucose state
GB201407896D0 (en) * 2014-05-05 2014-06-18 Joanneum Res Forschungsgmbh Insulin dosage proposal system
US10617363B2 (en) 2015-04-02 2020-04-14 Roche Diabetes Care, Inc. Methods and systems for analyzing glucose data measured from a person having diabetes
US10657224B2 (en) 2015-09-25 2020-05-19 Accenture Global Solutions Limited Monitoring and treatment dosage prediction system
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
US10304315B2 (en) 2016-06-09 2019-05-28 Amp Llc Systems and methods for health monitoring and providing emergency support
US20190287645A1 (en) 2016-07-06 2019-09-19 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids
US10971030B2 (en) 2017-01-26 2021-04-06 International Business Machines Corporation Remote physical training

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110319322A1 (en) * 2008-04-04 2011-12-29 Hygieia, Inc. Systems, Methods and Devices for Achieving Glycemic Balance
US20120232520A1 (en) * 2011-03-10 2012-09-13 Abbott Diabetes Care Inc. Multi-Function Analyte Monitor Device and Methods of Use
TW201318602A (zh) * 2011-11-14 2013-05-16 Joinsoon Medical Technology Co Ltd 具胰島素參數之血糖檢測統計方法及其血糖檢測機

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
朱娅梅等: "动态血糖监测系统在儿童糖尿病中的应用", 药品评价, vol. 8, no. 11, 31 December 2011 (2011-12-31), pages 22 - 24 *

Also Published As

Publication number Publication date
EP3639268B1 (en) 2024-10-09
EP3758008A1 (en) 2020-12-30
JP2022095682A (ja) 2022-06-28
JP7389834B2 (ja) 2023-11-30
EP3639268A1 (en) 2020-04-22
US12109392B2 (en) 2024-10-08
US20220184310A1 (en) 2022-06-16
US20210146046A1 (en) 2021-05-20
US11298461B2 (en) 2022-04-12
JP7178370B2 (ja) 2022-11-25
MA49422A (fr) 2020-04-22
CN110741438B (zh) 2023-12-29
JP2020524844A (ja) 2020-08-20
CN110741438A (zh) 2020-01-31

Similar Documents

Publication Publication Date Title
US11373746B2 (en) Basal titration with adaptive target glucose level
CN109690685B (zh) 用于确定胰岛素敏感性的系统和方法
JP7389834B2 (ja) 適合可能な標的グルコースレベルを用いる基礎タイトレーション
US11195607B2 (en) Starter kit for basal rate titration
US11282598B2 (en) Starter kit for basal insulin titration
US11631486B2 (en) Systems and methods for optimization of bolus timing relative to meal events
US11295847B2 (en) Systems and methods for adjusting basal administration timing
EP3500962B1 (en) System and method for adjusting a basal/bolus ratio in an insulin regimen
CN109416945B (zh) 用于基于葡萄糖测量结果和胰岛素笔数据的胰岛素治疗的方案遵守措施
WO2018153648A1 (en) Systems and methods for communicating a dose
WO2018228932A1 (en) Basal titration with adaptive target glucose level

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination